S. Jacobelli

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Sergio H Jacobelli, Sergio h. Jacobelli, Sergio Jacobelli, Sergio H. Jacobelli, S. Jacobelli, S Jacobelli
Publication record
86 papers · 1,999 citations · H-index 27

PAPERS

Calcium Pyrophosphate Dihydrate Crystal Deposition in Neuropathic Joints
20200 citationsauthor #1
CS-08 Effect of antimalarials over the different domains of the damage index in latin american SLE patients
20180 citationsauthor #48
CE-46 Influence of solar radiation in cutaneous manifestations of lupus: data from the gladel cohort
20161 citationsauthor #11
Beginning to Explore the High Rate of Work Limitation in Patients With Rheumatoid Arthritis in Chile.
20152 citationsauthor #4
Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
201558 citationsauthor #5
Tolerogenic dendritic cells as a therapy for treating lupus.
201344 citationsauthor #4
Carbon monoxide exposure improves immune function in lupus‐prone mice
201339 citationsauthor #5
DCs : dendritic cells HO-1 : hemeoxygenase 1 SLE : systemic lupus erithematosus
20130 citationsauthor #5
Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus
201235 citationsauthor #9
Heme oxygenase-1 expression were decreased in monocytes from Systemic Lupus Erithematosus patients (119.6)
20120 citationsauthor #7
Heme oxygenase-1 expression were decreased in monocytes from Systemic Lupus Erithematosus patients
20120 citationsauthor #7
Weakassociation between HLA-DR4and rheumatoid arthritis inChilean patients
20110 citationsauthor #2
Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity
2011103 citationsauthor #9
Genetic and pharmacological modulation of dendritic cell-T cell interactions as a therapeutic strategy for systemic lupus erythematosus.
20117 citationsauthor #5
[Extensive cerebral vein thrombosis as first manifestation of Behçet's disease. Report of one case].
20107 citationsauthor #2
[Pseudotumor cerebri secondary to Behçet disease. Report of one case].
20101 citationsauthor #3
Disease activity in systemic lupus erythematosus is associated with an altered expression of low‐affinity Fcγ receptors and costimulatory molecules on dendritic cells
200960 citationsauthor #4
Modulation of nuclear factor‐κB activity can influence the susceptibility to systemic lupus erythematosus
200958 citationsauthor #10
Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children
2008144 citationsauthor #67
Activating and inhibitory Fcγ receptors can differentially modulate T cell‐mediated autoimmunity
200832 citationsauthor #5
Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
2007116 citationsauthor #1
Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis
2007182 citationsauthor #10
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
200739 citationsauthor #11
Lymphoid B cells induce NF-kappaB activation in high endothelial cells from human tonsils.
20061 citationsauthor #4
Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
200647 citationsauthor #7
Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells.
200693 citationsauthor #9
[Antibodies against galectin-8 in patients with systemic lupus erythematosus].
200613 citationsauthor #5
[Clinical features of Wegener granulomatosis and microscopic polyangiitis in Chilean patients].
200515 citationsauthor #3
[Paget disease of bone in Chile: report of 15 cases].
20035 citationsauthor #5
[Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment].
20033 citationsauthor #4
Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment
20031 citationsauthor #4
Outcome of Chilean Patients with Lupus Nephritis and Response to Intravenous Cyclophosphamide
200313 citationsauthor #8
Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease
200259 citationsauthor #8
[Eosinophilic fasciitis: report of 3 cases].
20024 citationsauthor #6
Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
200239 citationsauthor #5
The presence of the HLA-DRB1 shared epitope correlates with erosive disease in Chilean patients with rheumatoid arthritis.
200219 citationsauthor #6
Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.
200245 citationsauthor #3
Catastrophic antiphospholipid syndrome associated with crescentic glomerulonephritis: a clinicopathologic case.
200015 citationsauthor #5
Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
200033 citationsauthor #8
[Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
19991 citationsauthor #9
Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus
199878 citationsauthor #5
Influence of the HLA-DRβ shared epitope on susceptibility to and clinical expression of rheumatoid arthritis in Chilean patients
199733 citationsauthor #7
Association of primary antiphospholipid syndrome with primary adrenal insufficiency.
199612 citationsauthor #6
Occasional Series: Lupus Around the World The Chilean experience of systemic lupus erythematosus
19965 citationsauthor #2
[Seronegative arthritis: reexamination of the initial diagnosis and prognosis after 10 years].
19960 citationsauthor #7
[Infection and reactive arthritis: clinico-bacteriological correlation in seronegative arthropathies].
19953 citationsauthor #2
[Treatment with cyclosporine of refractory rheumatoid arthritis].
19950 citationsauthor #2
Survival of Chilean patients with systemic lupus erythematosus.
199487 citationsauthor #3
[Renal and respiratory failure in a pregnant woman with progressive systemic sclerosis. Anatomo-clinical case].
19942 citationsauthor #4
[Juvenile systemic rheumatoid arthritis and adult-onset Still's disease: comparison of clinical course].
19921 citationsauthor #3
Anticardiolipin antibodies in acute rheumatic fever.
199263 citationsauthor #7
Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis.
199235 citationsauthor #6
High-Dose Intravenous Methylprednisolone Therapy Associated with Osteonecrosis in Patients with Systemic Lupus Erythematosus
199272 citationsauthor #2
Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients.
199027 citationsauthor #2
[Osteomalacia and renal tubular acidosis associated with analgesic abuse. A clinical case].
19901 citationsauthor #6
[Maternal connective tissue disease associated with congenital AV block].
19895 citationsauthor #7
Amyloidosis secondary to gout. Identification with a monoclonal antibody to amyloid protein A.
19886 citationsauthor #1
[Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study].
198713 citationsauthor #3
[Systemic lupus erythematosus without changes in the examination of the urine].
19872 citationsauthor #2
[Acute glomerulonephritis in children. Prospective study of clinical, histopathologic and immunologic aspects].
19870 citationsauthor #8
[Humoral and cellular immunity changes in active rheumatic disease in the adult].
19870 citationsauthor #2
Cholesterol distribution among lipoprotein fractions in patients with gout and normal controls.
19869 citationsauthor #1
[Rheumatological aspects of the painful shoulder].
19860 citationsauthor #1
[Anti-DNA antibodies in systemic lupus erythematosus. Study of 2 methods of detection].
19852 citationsauthor #3
[Survival of patients with lupus nephropathy. II. Prognostic factors].
19852 citationsauthor #2
[Analysis of the mortality of patients with systemic lupus erythematosus. I].
19851 citationsauthor #1
[Articular manifestations of ulcerative colitis: experience with 88 patients].
19840 citationsauthor #1
[Autoimmune anemia and thrombopenia in mixed connective tissue disease].
19831 citationsauthor #4
[Absorption of aspirin by the jejunal mucosa of rats].
19820 citationsauthor #1
[Antibodies to soluble nuclear antigens in connective tissue diseases].
19820 citationsauthor #2
[Nonsteroidal anti-inflammatory drugs (author's transl)].
19780 citationsauthor #1
Inorganic pyrophosphatase activity of the synovial fluid. Kinetic and clinical study.
19781 citationsauthor #1
Inorganic pyrophosphatase activity of the synovial fluid.
197814 citationsauthor #1
[Arthritis due to Candida albicans (author's transl)].
19780 citationsauthor #2
Candida arthritis associated with positive birefringent crystals without chondrocalcinosis.
19776 citationsauthor #2
Transient osteoporosis of the hip.
197716 citationsauthor #3
[Reiter's syndrome (author's transl)].
19760 citationsauthor #2
[Familial articular chondrocalcinosis in the Chiloe Islands (Chile) (author's transl)].
19761 citationsauthor #7
[Lupus nefropathy. A clinical-morphologic correlation (author's transl)].
19761 citationsauthor #2
Diseases associated with calcium pyrophosphate dihydrate crystal deposition.
197472 citationsauthor #4
[Plasmatic neutral inorganic pyrophosphatase and alkaline phosphatase activities in patients with chondrocalcinosis and controls (author's transl)].
19741 citationsauthor #1
Identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin.
197340 citationsauthor #2
Calcium pyrophosphate dihydrate crystal deposition in neuropathic joints. Four cases of polyarticular involvement.
197350 citationsauthor #1
Septic Arthritis in Sickle-Cell States: Pathophysiology of Impaired Response to Infection and Implications for Management.
19723 citationsauthor #3
[CUTANEOUS AND RETICULOENDOTHELIAL MANIFESTATIONS INDUCED BY HYDANTOIN DERIVATIVES].
19640 citationsauthor #4
rheumatoid arthritis in Chilean patients . Weak association between HLA-DR 4 and
year unknown0 citationsauthor #2

TIMELINE

1964 0 citations

1972 3 citations

1973 90 citations

1974 73 citations

1976 2 citations

1977 22 citations

1978 15 citations

1982 0 citations

1983 1 citations

1984 0 citations

1985 5 citations

1986 9 citations

1987 15 citations

1988 6 citations

1989 5 citations

1990 28 citations

1992 171 citations

1994 89 citations

1995 3 citations

1996 17 citations

1997 33 citations

1998 78 citations

1999 1 citations

2000 48 citations

2002 166 citations

2003 22 citations

2005 15 citations

2006 154 citations

2007 337 citations

2008 176 citations

2009 118 citations

2010 8 citations

2011 110 citations

2012 35 citations

2013 83 citations

2015 60 citations

2016 1 citations

2018 0 citations

2020 0 citations

Unknown 0 citations

S. Jacobelli

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT